1. Home
  2. AUDC vs ESPR Comparison

AUDC vs ESPR Comparison

Compare AUDC & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$8.80

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.71

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
ESPR
Founded
1992
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.0M
898.5M
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
AUDC
ESPR
Price
$8.80
$3.71
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$11.67
$6.67
AVG Volume (30 Days)
92.8K
5.3M
Earning Date
02-03-2026
11-06-2025
Dividend Yield
4.53%
N/A
EPS Growth
15.76
N/A
EPS
0.46
N/A
Revenue
$244,553,000.00
$303,802,000.00
Revenue This Year
$2.98
$26.11
Revenue Next Year
$3.40
N/A
P/E Ratio
$19.02
N/A
Revenue Growth
0.15
2.83
52 Week Low
$8.01
$0.69
52 Week High
$12.72
$4.13

Technical Indicators

Market Signals
Indicator
AUDC
ESPR
Relative Strength Index (RSI) 44.70 50.54
Support Level $8.79 $3.87
Resistance Level $8.96 $4.05
Average True Range (ATR) 0.20 0.20
MACD -0.01 -0.04
Stochastic Oscillator 14.97 15.00

Price Performance

Historical Comparison
AUDC
ESPR

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: